On 13 May 2017
Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 13 May 2017, to approve the Audited Financial Results (Standalone & Consolidated)of the Company under Ind AS for the fourth quarter and year ended 31 March 2017Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content